GB9910320D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9910320D0
GB9910320D0 GBGB9910320.2A GB9910320A GB9910320D0 GB 9910320 D0 GB9910320 D0 GB 9910320D0 GB 9910320 A GB9910320 A GB 9910320A GB 9910320 D0 GB9910320 D0 GB 9910320D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9910320.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB9910320.2A priority Critical patent/GB9910320D0/en
Publication of GB9910320D0 publication Critical patent/GB9910320D0/en
Priority to CO99052292A priority patent/CO5130010A1/en
Priority to MYPI9903543 priority patent/MY128958A/en
Priority to MYPI0304586 priority patent/MY152490A/en
Priority to TW88114109A priority patent/TWI238725B/en
Priority to PE1999000837A priority patent/PE20000865A1/en
Priority to AU56232/99A priority patent/AU762829B2/en
Priority to DK99942892T priority patent/DK1104289T3/en
Priority to TR2001/02259T priority patent/TR200102259T2/en
Priority to DE69929703T priority patent/DE69929703T2/en
Priority to CA002338794A priority patent/CA2338794C/en
Priority to KR10-2001-7002161A priority patent/KR100529659B1/en
Priority to CNA2004100638733A priority patent/CN1589906A/en
Priority to AT99942892T priority patent/ATE316782T1/en
Priority to EEP200100104A priority patent/EE05054B1/en
Priority to YUP-87/01A priority patent/RS50104B/en
Priority to HU0103431A priority patent/HU228179B1/en
Priority to PL380173A priority patent/PL200132B1/en
Priority to NZ509832A priority patent/NZ509832A/en
Priority to SI9930892T priority patent/SI1104289T1/en
Priority to PL99346764A priority patent/PL194069B1/en
Priority to TR2004/00187T priority patent/TR200400187T2/en
Priority to IL14123699A priority patent/IL141236A0/en
Priority to CZ20010619A priority patent/CZ300647B6/en
Priority to EP99942892A priority patent/EP1104289B1/en
Priority to CNB998099244A priority patent/CN1165293C/en
Priority to IDW20010318A priority patent/ID28510A/en
Priority to PCT/EP1999/006083 priority patent/WO2000010526A2/en
Priority to IT1999MI001826A priority patent/IT1314185B1/en
Priority to JP2000565848A priority patent/JP4048024B2/en
Priority to BR9913135-8A priority patent/BR9913135A/en
Priority to TR2001/00361T priority patent/TR200100361T2/en
Priority to ARP990104165 priority patent/AR018465A1/en
Priority to SK243-2001A priority patent/SK285255B6/en
Priority to ES99942892T priority patent/ES2257869T3/en
Priority to FR9910666A priority patent/FR2782454B1/en
Priority to FR9914897A priority patent/FR2784899B1/en
Priority to IS5851A priority patent/IS2369B/en
Priority to FR0010748A priority patent/FR2799123B1/en
Priority to BG105257A priority patent/BG65322B1/en
Priority to HR20010123A priority patent/HRP20010123B1/en
Priority to NO20010863A priority patent/NO328756B1/en
Priority to ARP010103838A priority patent/AR030340A2/en
Priority to HK01107619A priority patent/HK1038179A1/en
Priority to US10/620,178 priority patent/US20030236183A1/en
Priority to AU2003248212A priority patent/AU2003248212A1/en
Priority to AU2006200048A priority patent/AU2006200048A1/en
Priority to US11/947,769 priority patent/US20080075773A1/en
Priority to AU2009200403A priority patent/AU2009200403A1/en
Priority to US13/303,459 priority patent/US20120071537A1/en
Priority to US13/755,444 priority patent/US20130158092A1/en
Ceased legal-status Critical Current

Links

GBGB9910320.2A 1998-08-21 1999-05-05 Organic compounds Ceased GB9910320D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds
CO99052292A CO5130010A1 (en) 1998-08-21 1999-08-18 PHARMACEUTICAL COMPOSITIONS TO ADMINISTER ACTIVE AGENTS ACTING ON THE GASTROINTESTINALY SYSTEM THAT ARE POORLY SOLUBLE IN AQUARIUS MEDIA AND SENSITIVE TO ACID
MYPI9903543 MY128958A (en) 1998-08-21 1999-08-18 New oral formulation for 5-ht4 agonists or antagonists.
MYPI0304586 MY152490A (en) 1998-08-21 1999-08-18 New oral formulation
TW88114109A TWI238725B (en) 1998-08-21 1999-08-18 Solid oral pharmaceutical composition and process for preparing the same
PE1999000837A PE20000865A1 (en) 1998-08-21 1999-08-18 ORAL FORMULATIONS OF 5-HT4 RECEPTOR AGONISTS OR ANTAGONISTS
AU56232/99A AU762829B2 (en) 1998-08-21 1999-08-19 New oral formulation for 5-HT4 agonists or antagonists
DK99942892T DK1104289T3 (en) 1998-08-21 1999-08-19 New oral formulations for 5-HT 4 agonists or antagonists
TR2001/02259T TR200102259T2 (en) 1998-08-21 1999-08-19 New oral formulation
DE69929703T DE69929703T2 (en) 1998-08-21 1999-08-19 NEW ORAL FORMULATIONS FOR 5-HT4 AGONISTS OR ANTAGONISTS
CA002338794A CA2338794C (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists
KR10-2001-7002161A KR100529659B1 (en) 1998-08-21 1999-08-19 New Oral Formulation for 5-HT4 Agonists or Antagonists
CNA2004100638733A CN1589906A (en) 1998-08-21 1999-08-19 New oral formulation for 5-HT4 agonists or antagonists
AT99942892T ATE316782T1 (en) 1998-08-21 1999-08-19 NEW ORAL FORMULATIONS FOR 5-HT4 AGONISTS OR ANTAGONISTS
EEP200100104A EE05054B1 (en) 1998-08-21 1999-08-19 Oral pharmaceutical composition of a 5-HT4 agonist or antagonist and its use in medicine
YUP-87/01A RS50104B (en) 1998-08-21 1999-08-19 New oral formulation for 5-th4 agonists or antagonists
HU0103431A HU228179B1 (en) 1998-08-21 1999-08-19 Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
PL380173A PL200132B1 (en) 1998-08-21 1999-08-19 Application of 3-(5-methoxy-1H-indole-3-methylene)-N-pentyl carbazyl imidoamide
NZ509832A NZ509832A (en) 1998-08-21 1999-08-19 New oral formulation for 5-HT4 agonists or antagonists
SI9930892T SI1104289T1 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists
PL99346764A PL194069B1 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4
TR2004/00187T TR200400187T2 (en) 1998-08-21 1999-08-19 New oral formulation.
IL14123699A IL141236A0 (en) 1998-08-21 1999-08-19 New oral formulations for 5-ht4 agonists or antagonists
CZ20010619A CZ300647B6 (en) 1998-08-21 1999-08-19 Solid pharmaceutical composition for peroral administration comprising tegaserod or pharmaceutically acceptable salt thereof
EP99942892A EP1104289B1 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists
CNB998099244A CN1165293C (en) 1998-08-21 1999-08-19 New oral formulation for 5-HT4 agonists or antagonists
IDW20010318A ID28510A (en) 1998-08-21 1999-08-19 NEW ORAL FORMULATION FOR AGONISTS OR 5-HT4 ANTAGONISTS
PCT/EP1999/006083 WO2000010526A2 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists
IT1999MI001826A IT1314185B1 (en) 1998-08-21 1999-08-19 PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF SUBSTANCES ACTIVELY SOLUBLE IN AQUEOUS MEDIA
JP2000565848A JP4048024B2 (en) 1998-08-21 1999-08-19 New oral formulation
BR9913135-8A BR9913135A (en) 1998-08-21 1999-08-19 Oral formulation
TR2001/00361T TR200100361T2 (en) 1998-08-21 1999-08-19 New oral formulation
ARP990104165 AR018465A1 (en) 1998-08-21 1999-08-19 ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY,
SK243-2001A SK285255B6 (en) 1998-08-21 1999-08-19 Solid peroral pharmaceutical composition and use thereof
ES99942892T ES2257869T3 (en) 1998-08-21 1999-08-19 NEW ORAL FORMULATION FOR AGONISTS OR ANTAGONISTS OF 5-HT4.
FR9910666A FR2782454B1 (en) 1998-08-21 1999-08-20 SOLID ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACID SENSITIVE AGENT AND / OR LITTLE SOLUBLE IN AQUEOUS MEDIUM AND A DEAGRANGER, AND THE USE OF SAID COMPOSITION
FR9914897A FR2784899B1 (en) 1998-08-21 1999-11-26 AGONIST, PARTIAL AGONIST OR ANTAGONIST OF THE 5-HT4 RECEPTOR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION, INCLUDING FOR VETERINARY USE
IS5851A IS2369B (en) 1998-08-21 2000-02-20 New oral 5-HT4 agonist or oral antagonist
FR0010748A FR2799123B1 (en) 1998-08-21 2000-08-21 SOLID ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACID SENSITIVE AND / OR LITTLE SOLUBLE AGENT IN AN AQUEOUS MEDIUM AND A DISAGREGENT, AND USE OF THE COMPOSITION
BG105257A BG65322B1 (en) 1998-08-21 2001-02-14 Oral formulation for 5-ht4 agonists or antagonists
HR20010123A HRP20010123B1 (en) 1998-08-21 2001-02-20 New oral formulation 5-ht4 agonists or antagonists
NO20010863A NO328756B1 (en) 1998-08-21 2001-02-20 Oral formulations for 3- (5-methoxy-1H-indol-3yl-methylene) -N-pentylcarbazimidamide and use thereof
ARP010103838A AR030340A2 (en) 1998-08-21 2001-08-10 METHOD TO PREVENT, MODULATE, OR TREAT VISCERAL PAIN OR DISORDER, TO MODULATE VISCERAL SENSITIVITY OR PERCEPTION, TO IMPROVE THE SENSORY PERCEPTION OF RECTAL DISTENSION, OR TO TREAT ANAL AND AGONISTIC CONTINENCE DIFFERENCES, AGONIST RECORDER 5 WHAT IS USED AND
HK01107619A HK1038179A1 (en) 1998-08-21 2001-10-31 New oral formulation for 5-ht4 agonists or antagonists
US10/620,178 US20030236183A1 (en) 1998-08-21 2003-07-15 Oral formulation
AU2003248212A AU2003248212A1 (en) 1998-08-21 2003-09-22 New oral formulation for 5-HT4 agonists or antagonists
AU2006200048A AU2006200048A1 (en) 1998-08-21 2006-01-06 New oral formulation for 5-HT4 agonists or antagonists
US11/947,769 US20080075773A1 (en) 1998-08-21 2007-11-29 New Oral Formulation
AU2009200403A AU2009200403A1 (en) 1998-08-21 2009-02-04 New oral formulation for 5-HT4 agonists or antagonists
US13/303,459 US20120071537A1 (en) 1998-08-21 2011-11-23 New Oral Formulation
US13/755,444 US20130158092A1 (en) 1998-08-21 2013-01-31 New Oral Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds

Publications (1)

Publication Number Publication Date
GB9910320D0 true GB9910320D0 (en) 1999-06-30

Family

ID=10852796

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9910320.2A Ceased GB9910320D0 (en) 1998-08-21 1999-05-05 Organic compounds

Country Status (1)

Country Link
GB (1) GB9910320D0 (en)

Similar Documents

Publication Publication Date Title
GB9903759D0 (en) Organic compounds
GB9903547D0 (en) Organic compounds
GB9907097D0 (en) Organic compounds
GB9908533D0 (en) Organic compounds
GB9903548D0 (en) Organic compounds
GB9902938D0 (en) Organic compounds
GB9907908D0 (en) Organic compounds
GB9910119D0 (en) Organic compounds
GB9910965D0 (en) Organic compounds
GB9905946D0 (en) Organic compounds
GB9903949D0 (en) Organic compounds
GB9910319D0 (en) Organic compounds
GB9910243D0 (en) Organic compounds
GB9910835D0 (en) Organic compounds
GB9909333D0 (en) Organic compounds
GB9911059D0 (en) Organic compounds
GB9908532D0 (en) Organic compounds
GB9908531D0 (en) Organic compounds
GB9910320D0 (en) Organic compounds
GB9907823D0 (en) Organic compounds
GB9907822D0 (en) Organic compounds
GB9911926D0 (en) Organic compounds
GB9907094D0 (en) Organic compounds
GB9906060D0 (en) Organic compounds
GB9912071D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)